II-Alpha Premium

Latest Articles

Scott Eisen/Bloomberg

Troubling Times for Ginkgo Bioworks

Stephen Taub March 16, 2022

Tiffany Hagler-Geard/Bloomberg

Online Grocer Instacart, a Tiger Fund Favorite, Takes a Valuation Hit

Stephen Taub March 15, 2022

Chase Coleman (Amanda Gordon/Bloomberg)

Tiger Global Changes Up Its Private Market Strategy

Stephen Taub March 14, 2022

The 2022 Rich List top five

The Complete Rich List: The 21st Annual Ranking of the Highest-Earning Hedge Fund Managers

Ava Luisa, Ailene Barona, Ailene The Tester March 10, 2022

Lee Ainslie (David Paul Morris/Bloomberg)

Maverick’s Roller Coaster Ride

Stephen Taub March 9, 2022

Nathan Laine/Bloomberg

Third Point Goes Activist on Cano Health

Stephen Taub March 9, 2022

Valiant Capital Management is based in San Francisco. (David Paul Morris/Bloomberg)

In a Down Market, Valiant Plays the Long Game

Stephen Taub March 8, 2022

Michael Nagle/Bloomberg

Impala Starts the Year With Big Gains

Stephen Taub March 7, 2022

Dan Loeb, CEO of Third Point (David Paul Morris/Bloomberg)

Third Point Extends Its Losing Streak

Stephen Taub March 7, 2022

Nazem Haidar (Victor J. Blue/Bloomberg)

Haidar Continues to Kill It

Stephen Taub March 4, 2022

Larry Robbins (Alex Flynn/Bloomberg)

Glenview Gets Off to a Strong Start

Stephen Taub March 2, 2022

IShares

A Factor Approach to ESG

Sponsored by iShares March 1, 2022

Carl Icahn (Andrew Harrer/Bloomberg)

Another Disappointing Year for Carl Icahn

Stephen Taub March 1, 2022

David Einhorn (Kholood Eid/Bloomberg)

Greenlight Surged in February as Markets Kept Falling

Stephen Taub March 1, 2022

Sculptor Capital headquarters in New York. (Andrew Harrer/Bloomberg)

Citi’s Advice to a Slumping Sculptor: Put Yourself Up for Sale

Stephen Taub February 25, 2022

Andrey Rudakov/Bloomberg

After a Tough 2021, RTW is Still Bullish

Stephen Taub February 23, 2022

Chris Ratcliffe/Bloomberg

Amazon Passes Microsoft as the Most Widely Held Hedge Fund Stock

Stephen Taub February 23, 2022

James MacDonald/Bloomberg

Biotech SPAC Mergers Rock These Hedge Funds

Stephen Taub February 22, 2022

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-18 Login